Bio Innovation Conference | Murat Kalayoglu, M.D., Ph.D., MBA
17691
page-template-default,page,page-id-17691,page-child,parent-pageid-16863,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-17.2,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-5.6,vc_responsive
 

Murat Kalayoglu, M.D., Ph.D., MBA

Murat Kalayoglu, M.D., Ph.D., MBA

President & CEO, Cartesian Therapeutics, Inc.

Dr. Kalayoglu is co-founder and CEO of Cartesian Therapeutics, a clinical stage biotechnology company developing novel cell and gene therapies to treat cancer and autoimmune diseases. Prior to Cartesian, he was co-founder and CEO of Topokine, which he led from concept to late-stage clinical trials, followed by a successful sale to Allergan (NYSE:AGN). Prior to Topokine, he was co-founder and COO of HealthHonors Corporation, which he led from concept to commercialization, followed by a successful sale to Healthways (NASDAQ:HWAY). Dr. Kalayoglu is a board-certified ophthalmologist who completed his residency and research Fellowship at Harvard, MD/PhD in immunology at the University of Wisconsin-Madison, and MBA from the MIT Sloan School of Management.

STAY INFORMED. Join our mailing list to receive our email newsletter.